 | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Mesoridazine.
|
Origin of the name
edit"Mesoridazine partially derives its name from the prefix "Meso"[citation needed] which means "middle" which is the center of the brain called the limbic system where most dopaminergic activity takes place."
I consider this assertion as highly doubtful; it may be somehow plausible, but I think, that "Mesoridazine" comes more likely from the chemical structure, where "Meso-" stands for Methylsulfonyl-, and -ridazine as a common base for piperidine-side-chain-phenotiazine neuroleptics. However, I didn't found a source for this speculation, so I will not change this statement in tis way; is it relevant enough to be incorporated into the article at the moment (at least, as long as unsourced)?--84.163.78.126 16:41, 16 August 2007 (UTC)
Changed to derived from MEthylSulfOxy- group, analog to Thioridazine. These articles are an attraction point to editors who wonder how everything is apparently connected to everything in the Universe. 70.137.164.136 (talk) 23:58, 1 August 2008 (UTC)
Withdrawn?
editThe lead says the drug was withdrawn in the US in 2004 due to safety concerns. The source for this is medlineplus.gov which does say it was withdrawn, and does say potentially life-threatening issues, but does not say it was withdrawn because of that. Moreover, the 2021 report] by the US FDA added here claims it was not withdrawn for safety issues. My guess is that it was voluntarily withdrawn in 2004, and not forced to be withdrawn. Does anyone know precisely what happened here? When/why it was withdrawn? Kimen8 (talk) 14:42, 3 September 2024 (UTC)